Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 398
Selected: 0
NCT IDTitle
NCT04469764Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
NCT00084747Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
NCT00003748Irinotecan in Treating Patients With Esophageal or Stomach Cancer
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT01059513Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT00096057Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer
NCT00004880Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
NCT07164027Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
NCT00335751PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
NCT04348682Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT00090896CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
NCT01532362Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer
NCT04007029Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
NCT00093769Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
NCT01204684Dendritic Cell Vaccine for Patients With Brain Tumors
NCT05775471Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
NCT01180907The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
NCT02336763Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases
NCT06447103An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer
NCT03623854Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
NCT00138164Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT01525264Breast Cancer Screening Intervention
NCT00003098Diet and Estrogen Metabolism in Postmenopausal Women
NCT00020878Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
NCT00301990Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT04290897Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
NCT00616642Rosiglitazone in Treating Patients With Pituitary Tumors
NCT02310594Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy
NCT03902951Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
NCT01783756Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
NCT07439484Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial
NCT03904251CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT04201873Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
NCT00090857Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00335868PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
NCT03732950Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
NCT04399824Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
NCT02928510Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
NCT04429204Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma
NCT01144247Cellular Immunotherapy Study for Brain Cancer
NCT05595499Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT00033514Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression
NCT04407546Role of Children in Transmission of COVID-19 to Immunocompromised Patients
NCT07118176Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT03541850Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT00072059Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT03672773Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT06387173Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
NCT07276438Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
NCT07191717Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial